Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
CLL extended 4

CLL FISH 1:Chronic Lymphocytic Leukemia with FISH for del17p, del11q (ATM Deletion), and Trisomy 12

Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that primarily affects white blood cells. The CLL FISH 1 test is a specialized diagnostic test that employs Fluorescence In Situ Hybridization (FISH) to analyze the genetic material in the blood cells affected by CLL. The test particularly looks for chromosomal abnormalities including deletion 17p (del17p), deletion 11q (ATM deletion), and Trisomy 12. These genetic markers are of paramount importance in understanding the complexity and severity of CLL, and in developing a tailor-made treatment approach.

The CLL FISH 1 test is particularly essential in pinpointing chromosomal aberrations that may be responsible for the development or progression of CLL. By detecting the deletion of chromosomes 17p and 11q, as well as Trisomy 12, this test plays a critical role in predicting the prognosis and guiding the therapeutic decisions for CLL.

  • Test NameCLL FISH 1:Chronic Lymphocytic Leukemia with FISH for del17p, del11q (ATM Deletion), and Trisomy 12
  • Sample TypeBlood/bone marrow
  • Preparations RequiredNo fasting is required. Inform your doctor of any medications or supplements you are taking.
  • Report Time5 days

What is the CLL FISH 1 test?

CLL FISH 1 is a diagnostic test that uses Fluorescence In Situ Hybridization (FISH) to analyze and detect specific chromosomal abnormalities in cells affected by Chronic Lymphocytic Leukemia. It focuses on identifying deletion 17p, deletion 11q (ATM deletion), and Trisomy 12.

Why is FISH used in this test?

FISH is used because it is a highly sensitive and specific method for detecting chromosomal abnormalities at a DNA level. It helps in visualizing specific DNA sequences on chromosomes and is instrumental in identifying deletions or additional copies of chromosomes, which can be critical in CLL.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

This test is essential in the management of CLL as it helps in predicting the course of the disease. For instance, deletion 17p is known to be associated with a poor response to certain chemotherapy drugs. Identifying these chromosomal abnormalities allows the doctor to choose the most appropriate treatment.

Deletion 17p is associated with a more aggressive form of CLL and resistance to standard chemotherapy. Deletion 11q signifies a more advanced disease and may be associated with rapid progression. Trisomy 12 is an extra copy of chromosome 12 and is associated with variable prognosis.

No specific preparation is needed. However, it's important to inform your doctor about any medications or supplements you are taking.

The frequency of this test depends on various factors including the stage of CLL, the patient’s response to treatment, and the doctor’s recommendations. It may be conducted at diagnosis, before starting a new treatment, or to monitor the course of the disease.

In normal cells, deletion 17p, deletion 11q, and Trisomy 12 are not present. The presence of these abnormalities in CLL cells indicates a chromosomal aberration.

If the test results are abnormal, it is advisable to consult a hematologist or an oncologist who specializes in blood cancers.

Technical errors and quality of the blood sample can affect the test results. The stage of the disease and any ongoing treatment may also have an impact.

As of now, CLL is considered a chronic disease. While there is no cure, it can often be managed effectively with treatment. Advances in therapy continue to improve the outlook for individuals with CLL.

The test involves a simple blood draw, and risks are minimal. These might include slight pain or bruising at the site where the needle was inserted.

Non-modifiable factors include age, gender, and genetics. Modifiable factors include exposure to certain chemicals and maintaining a healthy lifestyle.

Bone marrow transplant may be considered in some cases of CLL, especially for younger patients or those with a high-risk form of the disease. The suitability of a bone marrow transplant should be discussed with the doctor.

The CLL FISH 1 test is an essential component in the arsenal against Chronic Lymphocytic Leukemia. Its ability to detect chromosomal abnormalities provides invaluable information that can dictate the course of management and treatment. Armed with the knowledge that this test provides, doctors are better equipped to offer targeted therapies and interventions that can greatly improve the quality of life for individuals with CLL. Understanding your test and being proactive in communication with your doctor can significantly impact the journey through CLL.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet